Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk

International Journal of Molecular Epidemiology and Genetics

Volumn 3, Issue 2, 2012, Pages 96-106

  Eichholzer, Monika ^a   Rohrmann, Sabine ^a   Barbir, Aline ^a   Hermann, Silke ^b   Teucher, Birgit ^b   Kaaks, Rudolf ^b   Linseisen, Jakob ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Colorectal adenoma; Genetic polymorphisms; GSTA1; NAT1; NAT2

Indexed keywords

CYTOCHROME P450 1A2; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A9; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE P1; NAT 2 PROTEIN; NAT1 PROTEIN; PROTEIN; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ADULT; AGE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CALORIC INTAKE; CANCER RISK; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY FIBER; DNA POLYMORPHISM; ENZYME ACTIVITY; FAMILY HISTORY; FEMALE; FOOD INTAKE; GENDER; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAT; RISK ASSESSMENT; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84861770187     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Neugut AI, Garbowski GC, Lee WC, Murray T, Nieves JW, Forde KA, Treat MR, Waye JD and Fenoglio-Preiser C. Dietary risk factors for the incidence and recurrence of colorectal adeno- matous polyps. A case-control study. Ann Intern Med 1993; 118: 91-95.
2. Shin A, Shrubsole MJ, Ness RM, Wu H, Sinha R, Smalley WE, Shyr Y and Zheng W. Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp Study. Int J Cancer 2007; 121: 136-142.
3. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB and Willett WC. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 1992; 84: 91-98.
4. Tiemersma EW, Voskuil DW, Bunschoten A, Hogendoorn EA, Witteman BJ, Nagengast FM, Glatt H, Kok FJ and Kampman E. Risk of colo-rectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 2004; 15: 225-236.
5. World Cancer Research Fund AIfCR. Food, Nutrition, physical activity, and the prevention of cancer: A global perspective. Washington DC: AICR; 2007.
6. Vineis P and McMichael A. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control 1996; 7: 479-486.
7. Sugimura T, Wakabayashi K, Nakagama H and Nagao M. Heterocyclic amines: Mutagens/ carcinogens produced during cooking of meat and fish. Cancer Sci 2004; 95: 290-299.
8. Turesky RJ. The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr Drug Metab 2004; 5: 169-180.
9. Moonen H, Engels L, Kleinjans J and Kok T. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans. Cancer Lett 2005; 229: 25-31.
10. Hlavata I, Vrana D, Smerhovsky Z, Pardini B, Naccarati A, Vodicka P, Novotny J, Mohelnikova -Duchonova B and Soucek P. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol Rep 2010; 24: 1347-1353.
11. Goode EL, Potter JD, Bamlet WR, Rider DN and Bigler J. Inherited variation in carcinogen- metabolizing enzymes and risk of colorectal polyps. Carcinogenesis 2007; 28: 328-341.
12. Shin A, Shrubsole MJ, Rice JM, Cai Q, Doll MA, Long J, Smalley WE, Shyr Y, Sinha R, Ness RM, Hein DW and Zheng W. Meat intake, heterocyc-lic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 320-329.
13. Northwood EL, Elliott F, Forman D, Barrett JH, Wilkie MJ, Carey FA, Steele RJ, Wolf R, Bishop T and Smith G. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorec-tal adenoma risk. Pharmacogenet Genomics 2010; 20: 315-326.
14. van der Logt EM, Bergevoet SM, Roelofs HM, van Hooijdonk Z, te Morsche RH, Wobbes T, de Kok JB, Nagengast FM and Peters WH. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Car-cinogenesis 2004; 25: 2407-2415.
15. Nöthlings U, Yamamoto JF, Wilkens LR, Murphy SP, Park SY, Henderson BE, Kolonel LN and Le Marchand L. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2098-2106.
16. Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Sakamoto H, Yoshida T and Tsugane S. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan. Scand J Gastroenterol 2009; 44: 952-959.
17. Economopoulos KP and Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 2010; 46: 1617-1631.
18. Boeing H, Korfmann A and Bergmann MM. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999; 43: 205-215.
19. Kroke A, Bergmann MM, Lotze G, Jeckel A, Klip-stein-Grobusch K and Boeing H. Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 1999; 43: 216-224.
20. Magagnotti C, Pastorelli R, Pozzi S, Andreoni B, Fanelli R and Airoldi L. Genetic polymorphisms and modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA ad-ducts in human lymphocytes. Int J Cancer 2003; 107: 878-884.
21. Engelke CE, Meinl W, Boeing H and Glatt H. Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. Pharmacogenetics 2000; 10: 163-169.
22. Nordmark A, Lundgren S, Ask B, Granath F and Rane A. The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women. Br J Clin Pharmacol 2002; 54: 504-510.
23. Butler LM, Duguay Y, Millikan RC, Sinha R, Gagne JF, Sandler RS and Guillemette C. Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Bio-markers Prev 2005; 14: 1626-1632.
24. Yamanaka H, Nakajima M, Katoh M, Hara Y, Tachibana O, Yamashita J, McLeod HL and Yokoi T. A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics 2004; 14: 329-332.
25. Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002; 506-507: 65-77.
26. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ and Grant DM. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993; 14: 1633-1638.
27. Yeh CC, Sung FC, Tang R, Chang-Chieh CR and Hsieh LL. Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer. Dis Colon Rectum 2009; 52: 104-111.
28. Chen K, Jiang QT and He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 2005; 11: 331-335.
29. Nguyen TV, Janssen MJ, van Oijen MG, Ber-gevoet SM, te Morsche RH, van Asten H, Laheij RJ, Peters WH and Jansent JB. Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res 2010; 18: 349-355.
30. Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP and Kadlubar FF. Effect of polymorphism in the human glu-tathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenet-ics 2001; 11: 663-669.
31. Sachse C, Bhambra U, Smith G, Lightfoot TJ, Barrett JH, Scollay J, Garner RC, Boobis AR, Wolf CR and Gooderham NJ. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: al-lele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 2003; 55: 68-76.
32. Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH and Kang JH. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorec-tal cancer in Koreans. Cancer Sci 2006; 97: 774-779.
33. Strassburg CP, Vogel A, Kneip S, Tukey RH and Manns MP. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002; 50: 851-856.
34. Moreno V, Glatt H, Guino E, Fisher E, Meinl W, Navarro M, Badosa JM and Boeing H. Polymor-phisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Int J Cancer 2005; 113: 683-686.
35. Wong CF, Liyou N, Leggett B, Young J, Johnson A and McManus ME. Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin Exp Pharmacol Physiol 2002; 29: 754-758.
36. Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY and Chang JG. The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 2003; 11: 85-89.
37. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capella G and Canzian F. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 2005; 15: 535-546.
38. Sachse C, Smith G, Wilkie MJ, Barrett JH, Wax-man R, Sullivan F, Forman D, Bishop DT and Wolf CR. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002; 23: 1839-1849.
39. Nowell S, Coles B, Sinha R, MacLeod S, Luke Ratnasinghe D, Stotts C, Kadlubar FF, Am-brosone CB and Lang NP. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat Res 2002; 506-507: 175-185.
40. Lilla C, Verla-Tebit E, Risch A, Jager B, Hoffmeis-ter M, Brenner H and Chang-Claude J. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 2006; 15: 99-107.
41. Sun XF, Ahmadi A, Arbman G, Wallin A, Asklid D and Zhang H. Polymorphisms in sulfotrans-ferase 1A1 and glutathione S-transferase P1 genes in relation to colorectal cancer risk and patients' survival. World J Gastroenterol 2005; 11: 6875-6879.
42. Wang J, Jiang J, Zhao Y, Gajalakshmi V, Kuriki K, Suzuki S, Nagaya T, Nakamura S, Akasaka S, Ishikawa H and Tokudome S. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case-control study in an Indian population. Cancer Epidemiol 2011; 35: 66-72.
43. Rohrmann S, Hermann S and Linseisen J. Het-erocyclic aromatic amine intake increases colo-rectal adenoma risk: findings from a prospective European cohort study. Am J Clin Nutr 2009; 89: 1418-1424.